Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.8 |
mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.8 |